These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
636 related articles for article (PubMed ID: 31695808)
1. Integrin α Chen H; Zhao L; Fu K; Lin Q; Wen X; Jacobson O; Sun L; Wu H; Zhang X; Guo Z; Lin Q; Chen X Theranostics; 2019; 9(25):7948-7960. PubMed ID: 31695808 [TBL] [Abstract][Full Text] [Related]
2. Synergism of Wen X; Zeng X; Liu J; Zhang Y; Shi C; Wu X; Zhuang R; Chen X; Zhang X; Guo Z Bioconjug Chem; 2022 Nov; 33(11):2170-2179. PubMed ID: 36256849 [TBL] [Abstract][Full Text] [Related]
3. Combined VLA-4-Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma. Choi J; Beaino W; Fecek RJ; Fabian KPL; Laymon CM; Kurland BF; Storkus WJ; Anderson CJ J Nucl Med; 2018 Dec; 59(12):1843-1849. PubMed ID: 29959213 [TBL] [Abstract][Full Text] [Related]
4. α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8 Wang H; Lin X; Luo Y; Sun S; Tian X; Sun Y; Zhang S; Chen J; Zhang J; Liu X; Liu H; Gong Y; Xie C Immunotherapy; 2019 Feb; 11(2):101-118. PubMed ID: 30511887 [TBL] [Abstract][Full Text] [Related]
6. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a Ren J; Xu M; Chen J; Ding J; Wang P; Huo L; Li F; Liu Z Theranostics; 2021; 11(1):304-315. PubMed ID: 33391476 [No Abstract] [Full Text] [Related]
7. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis. Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993 [TBL] [Abstract][Full Text] [Related]
8. PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor Effect. Wen X; Zeng X; Cheng X; Zeng X; Liu J; Zhang Y; Li Y; Chen H; Huang J; Guo Z; Chen X; Zhang X Mol Pharm; 2022 Oct; 19(10):3612-3622. PubMed ID: 35652897 [TBL] [Abstract][Full Text] [Related]
9. Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine. Kim H; Khanna V; Kucaba TA; Zhang W; Ferguson DM; Griffith TS; Panyam J Mol Pharm; 2019 Mar; 16(3):1200-1210. PubMed ID: 30620878 [TBL] [Abstract][Full Text] [Related]
10. Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumors. Nagato T; Lee YR; Harabuchi Y; Celis E Clin Cancer Res; 2014 Mar; 20(5):1223-34. PubMed ID: 24389326 [TBL] [Abstract][Full Text] [Related]
11. Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model. Kim KJ; Kim JH; Lee SJ; Lee EJ; Shin EC; Seong J Oncotarget; 2017 Jun; 8(25):41242-41255. PubMed ID: 28465485 [TBL] [Abstract][Full Text] [Related]
12. Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models. Xu C; Zhang Y; Rolfe PA; Hernández VM; Guzman W; Kradjian G; Marelli B; Qin G; Qi J; Wang H; Yu H; Tighe R; Lo KM; English JM; Radvanyi L; Lan Y Clin Cancer Res; 2017 Oct; 23(19):5869-5880. PubMed ID: 28679778 [No Abstract] [Full Text] [Related]
16. Microwave ablation combined with PD-L1 blockade synergistically promotes Cxcl9-mediated antitumor immunity. He N; Huang H; Wu S; Ji W; Tai Y; Gao R; Liu Y; Liu Y; Chen L; Zhu D; Zheng X; Jiang J Cancer Sci; 2024 Jul; 115(7):2196-2208. PubMed ID: 38655660 [TBL] [Abstract][Full Text] [Related]
17. Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice. Li N; Tang J; Yang J; Zhu B; Wang X; Luo Y; Yang H; Jang F; Zou J; Liu Z; Wang Z Cancer Lett; 2021 Feb; 498():121-129. PubMed ID: 33129956 [TBL] [Abstract][Full Text] [Related]
18. Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model. Remy-Ziller C; Thioudellet C; Hortelano J; Gantzer M; Nourtier V; Claudepierre MC; Sansas B; Préville X; Bendjama K; Quemeneur E; Rittner K Hum Vaccin Immunother; 2018 Jan; 14(1):140-145. PubMed ID: 28925793 [TBL] [Abstract][Full Text] [Related]
19. Case Report: Huang JW; Kuo CL; Wang LT; Ma KS; Huang WY; Liu FC; Yang KD; Yang BH Front Immunol; 2021; 12():752563. PubMed ID: 35003064 [TBL] [Abstract][Full Text] [Related]